Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 263, Issue -, Pages 75-79Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2018.02.102
Keywords
Cardiopulmonary exercise testing; Peak oxygen consumption; Exercise capacity; Heart failure
Categories
Funding
- Australian Government Research Training Program (RTP) Scholarship
Ask authors/readers for more resources
Introduction: Percent of predicted peak VO2 (ppVO(2)) is considered a standard measure for establishing disease severiy, however, there are known limitations to traditional normative values. This study sought to compare ppVO(2) from the newly derived Fitness Registry and the Importance of Exercise: a Nalional Database (FRIEND) registry equation to conventional prediction equations in a clinical cohort of patients undergoing cardiopulmonary exercise Lusting (CPX). Methods and results: We selected 1094 patients referred for evaluation of heart failure (HF) symptoms who underwent CPX. ppVO(2) was calculated using he FRIEND, Wasserman/Hansen and Jones equations. Participants were followed for a median of 4.5 years [Interquartile range 3.5-6.0] for the composite endpoint of death, advanced HF therapy, or acute decompensated HF requiring hospital admission. Mean age was 48 +/- 15 years and 62%, were female. The FRIEND registry equation predicted the lowest ppVO(2) (measured/predicted; 71 31%), compared to theWasserman,4-lansen (74 +/- 29%,) and Jones equations (83 +/- 33%) (p < 0.001). All expressions of peak VO2 were significant as univariate predictors of outcome with no significant differences between equations on pairwise analysis of receiver operating characteristic curves. When compared at a similar threshold of ppVO(2) the event rate was significantly lower in the FRIEND registry equation versus the currently used Wasserman and Jones equations. Conclusion: The use of the newly derived FRIEND registry equation predicts HF outcomes; however, it appears to predict a higher predicted VO2; the clinical implication being a lower threshold of percent predicted peak VO2 should be considered when risk stratifying patients with HF. (C) 2018 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available